trending Market Intelligence /marketintelligence/en/news-insights/trending/tPupTwkRkbKGgXg9ZhssZQ2 content esgSubNav
In This List

Concert Pharmaceuticals CFO to quit

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Spotlight on sustainability: How banks can overcome the challenges of achieving net-zero emissions by 2050

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook


Concert Pharmaceuticals CFO to quit

Concert Pharmaceuticals Inc. CFO Ryan Daws will leave the company in June to join Baird as its managing director of life sciences and biotech.

Daws will continue to consult with Concert and help the company close the sale of its investigational cystic fibrosis drug CTP-656 to Vertex Pharmaceuticals Inc.

The company said it has initiated a search for a new CFO.